Recombinant factor VIIa

Results: 5



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

Add to Reading List

Source URL: labeling.cslbehring.com

Language: English - Date: 2016-05-26 14:29:43
2UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows  Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •

Add to Reading List

Source URL: www.nektar.com

Language: English - Date: 2015-07-30 13:12:07
350 The Use of Recombinant Factor VIIa* S. Sobieszczyk and G. H. Breborowicz INTRODUCTION

50 The Use of Recombinant Factor VIIa* S. Sobieszczyk and G. H. Breborowicz INTRODUCTION

Add to Reading List

Source URL: www.glowm.com

Language: English - Date: 2010-12-31 19:00:00
4NovoSeven RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable, Lyophilized Powder

NovoSeven RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable, Lyophilized Powder

Add to Reading List

Source URL: www.fda.gov

Language: English
5NovoSeven Coagulation Factor VIIa (Recombinant)

NovoSeven Coagulation Factor VIIa (Recombinant)

Add to Reading List

Source URL: www.fda.gov

Language: English